News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Imugene Limited (IMU.AX) Expands Technology Opps With New Company


10/19/2005 5:11:24 PM

Imugene (ASX:IMU) and the University of Adelaide have set up a new company to develop and commercialise human gastrointestinal applications of the receptor mimic technology (RMT), including cholera, rotavirus, 'travellers' diarrhoea', and antibiotic-associated diarrhoea.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES